Abbott LaboratoriesABT

NYSE · USA · Segment 6 of 8 in the Medicine, pharma & life science value chain: Diagnostics

American healthcare group with four divisions: diagnostics, medical devices (including glucose monitoring), nutrition and generics.

Diagnostics: Tests, imaging and assays that support clinical decision-making.

Key metrics

Market cap

$164B

Price

$94.13

Today

−0.3%

Return YTD

−24.7%

Return 1Y

−29.1%

P/E

26.2

P/S

3.6

P/B

3.2

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

DiagnosticsMedtech exposureDiabetes exposureMedtechDiabetes

In the value chain

Products & services

Diagnostics (in vitro)
Glucose monitoring (Libre)
Medical devices & nutrition

Competitors

Roche Diagnostics
Medtronic
DexCom

Risks

Declining covid testing
Broad portfolio

Same segment: Diagnostics

IDEXX LaboratoriesIDXX NateraNTRA Quest DiagnosticsDGX LabcorpLH HologicHOLX Bio-Rad LaboratoriesBIO

See where Abbott Laboratories sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →